# Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis

> **NCT01036022** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 120 (actual)

## Conditions studied

- Colitis, Ulcerative

## Interventions

- **DRUG:** GSK1399686

## Key facts

- **NCT ID:** NCT01036022
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09-15
- **Primary completion:** 2013-01-10
- **Final completion:** 2013-01-10
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2017-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01036022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01036022, "Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01036022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*